Surge in local biotech scene as public investments pay off
SINGAPORE – In a space that has been traditionally tough for startups to see rapid results or make quick profits, the local biotech scene has seen a surge in not only new companies formed, but also in valuation and clinical trial numbers.
More of them have…
Go to Source